Diabetes patient takes insulin

How the 340B Program Transforms Access to Vital Diabetes Medications

A New Groundbreaking Study Reveals Real-Life Impact, Cost Savings, and Barriers Faced by Underserved Diabetes Patients in Safety-Net Clinics   The federal 340B Drug Pricing Program provides discounted drug prices to safety-net entities, enabling them to serve more vulnerable patients. This program has become indispensable with the escalating costs of medications, including high-cost injectable diabetes…

Op-ed by Prominent Community Leaders Highlights Severe Damage of New York’s Proposed Medicaid Carve-out

On March 23, an op-ed written by three prominent community leaders, Ms. Hazel Dukes, Rev Kirsten John Foy, and Rev Dr. Johnnie Green, was published in several outlets, including savenysafetynet.com and empirereportnetwork.com.  Their op-ed highlights the severe damage that will be inflicted on vulnerable communities resulting from the impending policy of the New York Department…